172 related articles for article (PubMed ID: 25367098)
1. Intensity-modulated radiotherapy for laryngeal and hypopharyngeal cancer: minimization of late dysphagia without jeopardizing tumor control.
Modesto A; Laprie A; Vieillevigne L; Graff P; Sarini J; Vergez S; Delord JP; Farenc JC; Vigarios E; Filleron T; Rives M
Strahlenther Onkol; 2015 Mar; 191(3):225-33. PubMed ID: 25367098
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
Lambrecht M; Nevens D; Nuyts S
Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
[TBL] [Abstract][Full Text] [Related]
4. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
5. Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers.
Miah AB; Bhide SA; Guerrero-Urbano MT; Clark C; Bidmead AM; St Rose S; Barbachano Y; A'hern R; Tanay M; Hickey J; Nicol R; Newbold KL; Harrington KJ; Nutting CM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):539-47. PubMed ID: 21236602
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and outcome of intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy for oropharyngeal cancer: a matched-pair analysis.
Al-Mamgani A; Van Rooij P; Tans L; Teguh DN; Levendag PC
Technol Cancer Res Treat; 2013 Apr; 12(2):123-30. PubMed ID: 23098281
[TBL] [Abstract][Full Text] [Related]
7. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
8. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
[TBL] [Abstract][Full Text] [Related]
9. Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.
Geretschläger A; Bojaxhiu B; Dal Pra A; Leiser D; Schmücking M; Arnold A; Ghadjar P; Aebersold DM
Radiat Oncol; 2015 Jan; 10():20. PubMed ID: 25595218
[TBL] [Abstract][Full Text] [Related]
10. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservation.
Liu WS; Hsin CH; Chou YH; Liu JT; Wu MF; Tseng SW; Lee JK; Tseng HC; Wang TH; Su MC; Lee H
BMC Cancer; 2010 Mar; 10():102. PubMed ID: 20298550
[TBL] [Abstract][Full Text] [Related]
12. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
[TBL] [Abstract][Full Text] [Related]
13. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
[TBL] [Abstract][Full Text] [Related]
14. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
15. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of helical tomotherapy, intensity-modulated radiation therapy, volumetric-modulated arc therapy, and 3-dimensional conformal therapy for the treatment of T1N0 glottic cancer.
Ekici K; Pepele EK; Yaprak B; Temelli O; Eraslan AF; Kucuk N; Altınok AY; Sut PA; Alpak OD; Colak C; Mayadagli A
Med Dosim; 2016 Winter; 41(4):329-333. PubMed ID: 27765542
[TBL] [Abstract][Full Text] [Related]
17. Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.
Chen NB; Qiu B; Zhang J; Qiang MY; Zhu YJ; Wang B; Guo JY; Cai LZ; Huang SM; Liu MZ; Li Q; Hu YH; Li QW; Liu H
Cancer Res Treat; 2020 Jan; 52(1):31-40. PubMed ID: 31048664
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
[TBL] [Abstract][Full Text] [Related]
19. Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.
Huh G; Ahn SH; Suk JG; Lee MH; Kim WS; Kwon SK; Ock CY; Keam B; Heo DS; Kim JH; Wu HG
Jpn J Clin Oncol; 2020 Feb; 50(2):185-192. PubMed ID: 31711185
[TBL] [Abstract][Full Text] [Related]
20. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
